Evidence map›Paper›PMID 33897688›Full record

ArticleFrontiers in immunology2021

Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1-3 and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 in Whole Blood Cultures of Patients With Rheumatoid Arthritis.

Attila Balog, Borisz Varga, Ferenc Fülöp, Ildikó Lantos, Gergely Toldi, László Vécsei, Yvette Mándi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases.International journal of molecular sciences · 2021
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Attila BalogDepartment of Rheumatology and Immunology, University of Szeged, Szeged, Hungary.
Borisz VargaDepartment of Rheumatology and Immunology, University of Szeged, Szeged, Hungary.
Ferenc FülöpInstitute of Pharmaceutical Chemistry and Research Group for Stereochemistry, Hungarian Academy of Sciences, University of Szeged, Szeged, Hungary.
Ildikó LantosDepartment of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.
Gergely ToldiDepartment of Laboratory Medicine, Semmelweis University, Budapest, Hungary.
László VécseiDepartment of Neurology, University of Szeged, Szeged, Hungary.
Yvette MándiDepartment of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.
University of Szeged · HUHungarian Academy of Sciences · HUSemmelweis University · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Agedalpha-DefensinsAnti-Inflammatory AgentsArthritis, RheumatoidCell Adhesion MoleculesFemaleHumansInflammation MediatorsKynurenic AcidMaleMiddle AgedRheumatoid FactorS100 ProteinsStaphylococcus aureusTumor Necrosis Factor-alphaalpha-DefensinsAnti-Inflammatory AgentsCell Adhesion MoleculesInflammation MediatorsKynurenic AcidRheumatoid FactorS100 ProteinsSZR 72TNFAIP6 protein, humanTumor Necrosis Factor-alphacalgranulinsHNP1–3kynureninerheumatoid arthritisTNF-αTNFα-stimulated gene-6TSG-6

Identifiers

PMID33897688
PMCPMC8062753
OpenAlexW3153953809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.